✦ LIBER ✦

PCN82 Cost-Effectiveness Analysis of Erlotinib Versus Platinum Based Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations

✍ Scribed by P. Garrido; G. López-Vivanco; R. Rosell; B. Espinós; A. Castro-Gomez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN7 COMPARATIVE EFFECTIVENESS ASSESSMEN

✍ B. Schwander; J. de Castro Carpeño; D.F. Heigener; E. Wright; H.G. Bischoff; S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCN100 COST-EFFECTIVENESS OF GEFITINIB V

✍ J Jacob; M Henriksson; D Brattström 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Erlotinib as first-line treatment of Eur

✍ Petruzelka, Lubos 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 43 KB

PCN34 COST-EFFECTIVENESS OF GEFITINIB FO

✍ PH Liu; FC Hu; JD Wang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN76 Cost-Effectiveness of Erlotinib as

✍ M. Cobo; J. De Castro; D. Isla; I. Oyagüez; V. Lozano; A. Castro-Gomez 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Erlotinib versus chemotherapy as first-l

✍ Caicun Zhou; Yi-Long Wu; Gongyan Chen; Jifeng Feng; Xiao-Qing Liu; Changli Wang; 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 265 KB